125 related articles for article (PubMed ID: 29528980)
41. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population.
Bergman L; Nilsson B; Lundell G; Lundell M; Seregard S
Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063
[TBL] [Abstract][Full Text] [Related]
42. Local Recurrence Significantly Increases the Risk of Metastatic Uveal Melanoma.
Ophthalmic Oncology Task Force
Ophthalmology; 2016 Jan; 123(1):86-91. PubMed ID: 26505803
[TBL] [Abstract][Full Text] [Related]
43. Clinical predictors of survival in metastatic uveal melanoma.
Lorenzo D; Piulats JM; Ochoa M; Arias L; Gutiérrez C; Català J; Cobos E; Garcia-Bru P; Dias B; Padrón-Pérez N; Caminal JM
Jpn J Ophthalmol; 2019 Mar; 63(2):197-209. PubMed ID: 30796549
[TBL] [Abstract][Full Text] [Related]
44. Clinical and histopathological features of choroidal melanoma-related enucleated eyes in a Spanish tertiary hospital.
García Tirado A; Asencio Durán M; Berjón A; Ruiz Bravo-Burguillos E; Peralta Calvo J
Arch Soc Esp Oftalmol (Engl Ed); 2019 May; 94(5):225-231. PubMed ID: 30904338
[TBL] [Abstract][Full Text] [Related]
45. Long-term Risk of Melanoma-Related Mortality for Patients With Uveal Melanoma Treated With Proton Beam Therapy.
Lane AM; Kim IK; Gragoudas ES
JAMA Ophthalmol; 2015 Jul; 133(7):792-6. PubMed ID: 25905597
[TBL] [Abstract][Full Text] [Related]
46. Regression of uveal melanoma after plaque radiotherapy and thermotherapy based on chromosome 3 status.
Shields CL; Bianciotto C; Rudich D; Materin MA; Ganguly A; Shields JA
Retina; 2008 Oct; 28(9):1289-95. PubMed ID: 18628721
[TBL] [Abstract][Full Text] [Related]
47. CNS metastasis from malignant uveal melanoma: a clinical and histopathological characterisation.
Holfort SK; Lindegaard J; Isager P; Prause JU; Heegaard S
Br J Ophthalmol; 2009 May; 93(5):641-4. PubMed ID: 19091854
[TBL] [Abstract][Full Text] [Related]
48. Ciliary body medulloepithelioma: analysis of 41 cases.
Kaliki S; Shields CL; Eagle RC; Vemuganti GK; Almeida A; Manjandavida FP; Mulay K; Honavar SG; Shields JA
Ophthalmology; 2013 Dec; 120(12):2552-2559. PubMed ID: 23796765
[TBL] [Abstract][Full Text] [Related]
49. Influence of age on prognosis of young patients with uveal melanoma: a matched retrospective cohort study.
Kaliki S; Shields CL; Mashayekhi A; Ganesh A; Furuta M; Shields JA
Eur J Ophthalmol; 2013; 23(2):208-16. PubMed ID: 23065853
[TBL] [Abstract][Full Text] [Related]
50. Plaque radiotherapy for choroidal melanoma encircling the optic disc (circumpapillary choroidal melanoma).
Sagoo MS; Shields CL; Mashayekhi A; Freire J; Emrich J; Reiff J; Komarnicky L; Shields JA
Arch Ophthalmol; 2007 Sep; 125(9):1202-9. PubMed ID: 17846359
[TBL] [Abstract][Full Text] [Related]
51. Ten-year outcomes of uveal melanoma based on The Cancer Genome Atlas (TCGA) classification in 1001 cases.
Shields CL; Mayro EL; Bas Z; Dockery PW; Yaghy A; Lally SE; Ganguly A; Shields JA
Indian J Ophthalmol; 2021 Jul; 69(7):1839-1845. PubMed ID: 34146040
[TBL] [Abstract][Full Text] [Related]
52. Very long-term prognosis of patients with malignant uveal melanoma.
Kujala E; Mäkitie T; Kivelä T
Invest Ophthalmol Vis Sci; 2003 Nov; 44(11):4651-9. PubMed ID: 14578381
[TBL] [Abstract][Full Text] [Related]
53. Proton beam radiotherapy for uveal melanomas at nice teaching hospital: 16 years' experience.
Caujolle JP; Mammar H; Chamorey E; Pinon F; Herault J; Gastaud P
Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):98-103. PubMed ID: 19910136
[TBL] [Abstract][Full Text] [Related]
54. Uveal metastasis from lung cancer: clinical features, treatment, and outcome in 194 patients.
Shah SU; Mashayekhi A; Shields CL; Walia HS; Hubbard GB; Zhang J; Shields JA
Ophthalmology; 2014 Jan; 121(1):352-357. PubMed ID: 23988200
[TBL] [Abstract][Full Text] [Related]
55. Proton beam radiotherapy for uveal melanoma: results of Curie Institut-Orsay proton therapy center (ICPO).
Dendale R; Lumbroso-Le Rouic L; Noel G; Feuvret L; Levy C; Delacroix S; Meyer A; Nauraye C; Mazal A; Mammar H; Garcia P; D'Hermies F; Frau E; Plancher C; Asselain B; Schlienger P; Mazeron JJ; Desjardins L
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):780-7. PubMed ID: 16647221
[TBL] [Abstract][Full Text] [Related]
56. Survival from uveal melanoma in Western Australia 1981-2005.
Chew AL; Spilsbury K; Isaacs TW
Clin Exp Ophthalmol; 2015 Jul; 43(5):422-8. PubMed ID: 25556534
[TBL] [Abstract][Full Text] [Related]
57. A comparison of cause-specific melanoma mortality and all-cause mortality in survival analyses after radiation treatment for uveal melanoma.
Kroll S; Char DH; Quivey J; Castro J
Ophthalmology; 1998 Nov; 105(11):2035-45. PubMed ID: 9818602
[TBL] [Abstract][Full Text] [Related]
58. Pattern of Local Recurrence After I-125 Episcleral Brachytherapy for Uveal Melanoma in a Spanish Referral Ocular Oncology Unit.
Sánchez-Tabernero S; García-Alvarez C; Muñoz-Moreno MF; Diezhandino P; Alonso-Martínez P; de Frutos-Baraja JM; López-Lara F; Saornil MA
Am J Ophthalmol; 2017 Aug; 180():39-45. PubMed ID: 28572063
[TBL] [Abstract][Full Text] [Related]
59. Scleral necrosis in patients with posterior uveal melanomas evaluated by transcleral fine needle aspiration biopsy and treated by 125I plaque.
Correa ZM; Huth B; Augsburger JJ
Arq Bras Oftalmol; 2018; 81(4):330-335. PubMed ID: 29995126
[TBL] [Abstract][Full Text] [Related]
60. Risk factors for neovascular glaucoma after proton beam therapy of uveal melanoma: a detailed analysis of tumor and dose-volume parameters.
Mishra KK; Daftari IK; Weinberg V; Cole T; Quivey JM; Castro JR; Phillips TL; Char DH
Int J Radiat Oncol Biol Phys; 2013 Oct; 87(2):330-6. PubMed ID: 23886415
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]